TrialInternational journal of clinical oncology2024

Multicenter prospective phase II trial of concurrent chemoradiotherapy with weekly low-dose carboplatin for cisplatin-ineligible patients with advanced head and neck squamous cell carcinoma.

Yushi Ueki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.